Mount Carmel East Hospital
Columbus, Ohio, United States
Hospital in Columbus, Ohio
6001 E Broad St, Columbus, OH 43213
419 Beds
About Mount Carmel East Hospital
Mount Carmel East is a primary care hospital in Columbus, Ohio. Located on a 77-acre campus just outside of the suburb of Reynoldsburg, the hospital serves the east side of Columbus as well as other smaller communities.
There are 419 beds in Mount Carmel East Hospital.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
68
Alliance for Clinical Trials in Oncology
24
SWOG Cancer Research Network
22
ECOG-ACRIN Cancer Research Group
8
GOG Foundation
4
Medtronic Cardiac Rhythm and Heart Failure
4
Gynecologic Oncology Group
3
NRG Oncology
3
Wake Forest University Health Sciences
3
Abbott Medical Devices
2
Alliance Foundation Trials, LLC.
1
Clinical Trials at Mount Carmel East Hospital
During the past decade, Mount Carmel East Hospital conducted 108 clinical trials. In the 10-year time frame, 108 clinical trials started and 41 clinical trials were completed, i.e. on
average, 38% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 31 clinical trials were completed. i.e. 110.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
2005-11-01
2018-01-01
Completed
2,334
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Stress Management Therapy in Patients Receiving Chemotherapy for Cancer
2006-12-01
2010-05-01
Completed
442
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
2008-02-25
Active, not recruiting
165
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
2008-06-15
2015-05-28
Completed
210
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2012-06-18
Unknown status
1,070
AtriCure Exclusion of the LAA in Patients Undergoing Concomitant Cardiac Surgery
2008-09-01
2011-10-01
Completed
70
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Mount Carmel East Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 68 trials, followed by "Alliance for Clinical Trials in Oncology" with 24 trials
sponsored, "SWOG Cancer Research Network" with 22 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "GOG Foundation"
with 8 trials sponsored. Other sponsors include 20 different institutions and
companies that sponsored additional 20 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Carmel East Hospital"
#1 collaborator was "National Cancer Institute (NCI)" with 68 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 24 different institutions and companies that were
collaborators in the rest 34 trials.
Clinical Trials Conditions at Mount Carmel East Hospital
According to Clinical.Site data, the most researched conditions in "Mount Carmel East Hospital" are
"Recurrent Ovarian Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Invasive Breast Carcinoma" (6 trials), "Cervical Adenocarcinoma" (5 trials) and "HER2/Neu Negative" (5 trials). Many other conditions were trialed in "Mount Carmel East Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Mount Carmel East Hospital
Most popular intervention types in "Mount Carmel East Hospital" are "Drug" (105 trials), "Other" (93 trials), "Biological" (60 trials), "Procedure" (46 trials) and "Radiation" (12 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (48 trials), "Laboratory Biomarker Analysis" (36 trials), "Questionnaire Administration" (33 trials), "Biospecimen Collection" (28 trials) and "Computed Tomography" (27 trials). Other intervention names were less common.
Clinical Trials Genders at Mount Carmel East Hospital
The vast majority of trials in "Mount Carmel East Hospital" are
118 trials for "All" genders, 32 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Mount Carmel East Hospital
Currently, there are NaN active trials in "Mount Carmel East Hospital".
undefined are not yet recruiting,
49 are recruiting,
73 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Mount Carmel East Hospital,
2 suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Mount Carmel East Hospital, 4 "Phase 1"
clinical trials were conducted, 64 "Phase 2" clinical
trials and 71 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 12 trials that are defined as “Not Applicable".